ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 153 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,435,000 | -39.8% | 75,000 | -21.5% | 0.30% | -46.4% |
| Q1 2016 | $4,046,000 | +169.6% | 95,497 | +107.4% | 0.55% | +358.3% |
| Q1 2015 | $1,501,000 | -73.1% | 46,044 | -79.5% | 0.12% | -68.8% |
| Q3 2014 | $5,571,000 | +23.3% | 225,000 | +12.5% | 0.38% | +61.8% |
| Q2 2014 | $4,518,000 | +85.7% | 200,000 | +100.0% | 0.24% | +153.2% |
| Q1 2014 | $2,433,000 | -2.6% | 100,000 | 0.0% | 0.09% | -12.1% |
| Q4 2013 | $2,499,000 | -9.0% | 100,000 | 0.0% | 0.11% | -22.5% |
| Q3 2013 | $2,747,000 | -24.3% | 100,000 | -50.0% | 0.14% | -32.0% |
| Q2 2013 | $3,630,000 | – | 200,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |